{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:17:15Z","timestamp":1761895035858,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.urolonc.2009.12.003","type":"journal-article","created":{"date-parts":[[2010,3,8]],"date-time":"2010-03-08T05:49:01Z","timestamp":1268027341000},"page":"182-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract"],"prefix":"10.1016","volume":"30","author":[{"given":"Sylvia","family":"Scarpini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rapha\u00eble","family":"Renard-Penna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Camparo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Cussenot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Comp\u00e9rat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2009.12.003_bib1","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.urology.2007.12.026","article-title":"Gene expression study of Aurora-A reveals implication during bladder carcinogenesis and increasing values in invasive urothelial cancer","volume":"72","author":"Comperat","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2009.12.003_bib2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00428-007-0383-x","article-title":"Aurora-A\/STK-15 is a predictive factor for recurrent behavior in noninvasive bladder carcinoma: A study of 128 cases of noninvasive neoplasms","volume":"450","author":"Comperat","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1016\/j.urolonc.2009.12.003_bib3","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/cncr.20567","article-title":"Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement","volume":"101","author":"Frank","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2009.12.003_bib4","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1038\/sj.onc.1206964","article-title":"Distinct patterns of microsatellite instability are seen in tumors of the urinary tract","volume":"22","author":"Catto","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2009.12.003_bib5","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1136\/jmg.2003.017871","article-title":"Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma","volume":"41","author":"Roupret","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.urolonc.2009.12.003_bib6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0092-8674(92)90421-8","article-title":"p53 Function and dysfunction","volume":"70","author":"Vogelstein","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2009.12.003_bib7","first-page":"1699","article-title":"Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies","volume":"6","author":"Bartek","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2009.12.003_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2559.2002.01343.x","article-title":"Ki67 protein: The immaculate deception?","volume":"40","author":"Brown","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.urolonc.2009.12.003_bib9","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1442-2042.2005.01159.x","article-title":"The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter","volume":"12","author":"Kamijima","year":"2005","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2009.12.003_bib10","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.eururo.2005.07.005","article-title":"Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin, and MSH2 expression in upper urinary tract transitional cell carcinoma","volume":"48","author":"Fromont","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2009.12.003_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.urology.2005.08.065","article-title":"Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers","volume":"66","author":"Habuchi","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2009.12.003_bib12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0962-8924(99)01658-X","article-title":"The Aurora\/Ipl1p kinase family: Regulators of chromosome segregation and cytokinesis","volume":"9","author":"Bischoff","year":"1999","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.urolonc.2009.12.003_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.yexcr.2004.08.016","article-title":"Aurora kinases in spindle assembly and chromosome segregation","volume":"301","author":"Ducat","year":"2004","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.urolonc.2009.12.003_bib14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0302-2838(03)00056-3","article-title":"Centrosome hyperamplification and chromosomal instability in bladder cancer","volume":"43","author":"Kawamura","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2009.12.003_bib15","first-page":"1631","article-title":"Aurora-A\/STK15\/BTAK enhances chromosomal instability in bladder cancer cells","volume":"25","author":"Fraizer","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1016\/j.urolonc.2009.12.003_bib16","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/jnci\/94.17.1320","article-title":"Amplification\/overexpression of a mitotic kinase gene in human bladder cancer","volume":"94","author":"Sen","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2009.12.003_bib17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejso.2006.01.018","article-title":"Raf1, Aurora-A\/STK15 and E-cadherin biomarkers expression in patients with pTa\/pT1 urothelial bladder carcinoma: A retrospective TMA study of 246 patients with long-term follow-up","volume":"32","author":"Mhawech-Fauceglia","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.urolonc.2009.12.003_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/path.1711680114","article-title":"Immunohistologic detection of tumor growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues","volume":"168","author":"Gerdes","year":"1992","journal-title":"J Pathol"},{"key":"10.1016\/j.urolonc.2009.12.003_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0022-1759(92)90122-A","article-title":"An immunochemical analysis of the human nuclear phosphoprotein p53","volume":"151","author":"Vojtesek","year":"1992","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.urolonc.2009.12.003_bib20","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0090-4295(98)00295-7","article-title":"Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: A 30-year experience in 252 patients","volume":"52","author":"Hall","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2009.12.003_bib21","first-page":"225","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2009.12.003_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0022-5347(17)50936-2","article-title":"Analgesics and tobacco as risk factors for cancer of the ureter and renal pelvis","volume":"130","author":"McCredie","year":"1983","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.12.003_bib23","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1158\/1078-0432.CCR-07-4922","article-title":"Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth","volume":"14","author":"Lin","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2009.12.003_bib24","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0022-5347(05)67019-X","article-title":"Upper tract urothelial neoplasms: Incidence and survival during the last 2 decades","volume":"164","author":"Munoz","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.12.003_bib25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.ju.0000107767.56680.f7","article-title":"The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract","volume":"171","author":"Park","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.12.003_bib26","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.juro.2007.01.030","article-title":"Behavior of urothelial carcinoma with respect to anatomical location","volume":"177","author":"Catto","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.12.003_bib27","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.eururo.2006.11.021","article-title":"Transitional cell carcinoma of the ureter: Prognostic factors influencing progression and survival","volume":"51","author":"Lehmann","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2009.12.003_bib28","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.urology.2004.01.009","article-title":"Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma","volume":"63","author":"Zigeuner","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2009.12.003_bib29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1464-410x.2000.00726.x","article-title":"Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter","volume":"86","author":"Kamai","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2009.12.003_bib30","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.urology.2004.11.001","article-title":"Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract","volume":"65","author":"Hong","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2009.12.003_bib31","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.juro.2007.08.019","article-title":"Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically","volume":"178","author":"Saito","year":"2007","journal-title":"J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143909004037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143909004037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:59:09Z","timestamp":1761040749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143909004037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S1078143909004037"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2009.12.003","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2009.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}